TrialNature communications2024

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials.

Nhân Thị Hồ et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.